Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on April 2, 2025
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. FibroGen’s management team will be …
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
GlobeNewswire
·
April 2, 2025
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase …
GRI Bio Announces Closing of $5.0 Million Public Offering
GlobeNewswire
·
April 2, 2025
LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
GlobeNewswire
·
April 2, 2025
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial …
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
GlobeNewswire
·
April 2, 2025
Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential …
NeuroPace Announces Refocusing of Product Portfolio
GlobeNewswire
·
April 2, 2025
-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by the end of 2027 and Achievement of 20%+ Revenue CAGR -- …
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
April 2, 2025
FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
GlobeNewswire
·
April 2, 2025
Introduction of EluPro at Heart Rhythm 2025 in San Diego, April 25-27, 2025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, is proud to announce …
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14
GlobeNewswire
·
April 2, 2025
KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on …
BioCryst to Present at Upcoming Investor Conference
GlobeNewswire
·
April 2, 2025
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 9:30 a …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 2, 2025
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Bierman Autism Centers Partners with ASAT to Launch Limited-Edition Autism Awareness T-Shirt
EIN Presswire
·
April 2, 2025
Proceeds to Support Evidence-Based Autism Treatment and Education INDIANAPOLIS, IN, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- Bierman Autism Centers (BAC) is proud to announce its partnership with the Association for Science in Autism Treatment …
Marketstrat launches Markintel™ Methodology & Frameworks for Actionable Insights in MedTech & Healthcare
EIN Presswire
·
April 2, 2025
Markintel™ suite delivers evolving market intelligence for data-driven sectors, bridging insight gaps with actionable frameworks …
Outpatient Clinics Market Is Booming So Rapidly 2025-2032 - HCA Healthcare, Ascension Health, Kaiser Permanent,
EIN Presswire
·
April 2, 2025
BURLINGAME, CA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- The Latest study titled Outpatient Clinics Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value …
Clinical Diagnostic Market Is Booming So Rapidly 2025-2032 - Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Becton
EIN Presswire
·
April 2, 2025
BURLINGAME, CA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- The Latest study titled Clinical Diagnostic Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value …
Mexico In-Vitro Diagnostics Market Set to Witness Significant Growth by 2025-2032 | Siemens Healthineers, Abbott
EIN Presswire
·
April 2, 2025
BURLINGAME, CA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- The Latest study titled Mexico In-Vitro Diagnostics Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to …
Cancer Biomarkers Market Deep Research 2025-2032 | bioMérieux Inc., INOVIQ, Bio-Rad Laboratories Inc., Abbott
EIN Presswire
·
April 2, 2025
Global cancer biomarkers market is estimated to be valued at USD 28.90 Bn in 2025 and is expected to reach USD 67.62 Bn by 2032, exhibiting a CAGR of 12.9%. BURLINGAME, CA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- The Latest study titled …
Walking More. Stressing Less.
EIN Presswire
·
April 2, 2025
DALLAS, TX, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- Physical activity is one of the best ways to improve overall health and manage stress. Unfortunately, 1 in 4 adults in the U.S. are sedentary for more than eight hours each day, according to …
Enamine and ChemPass Collaborate to Accelerate Hit Discovery
EIN Presswire
·
April 2, 2025
KYIV, UKRAINE, April 2, 2025 /EINPresswire.com/ -- Enamine, the leading provider of chemical compounds and drug discovery services, and ChemPass, a contract research organization for computational and AI-assisted software, today announced their start of …